Uric acid, allopurinol therapy, and mortality in patients with acute heart failure — results of the Acute HEart FAilure Database registry

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

MÁLEK Filip OŠŤÁDAL Petr PAŘENICA Jiří JARKOVSKÝ Jiří VÍTOVEC Jiří WIDIMSKÝ Petr LINHART Aleš FEDORCO Marián COUFAL Zdeněk MIKLÍK Roman KRŰGER Andreas VONDRAKOVÁ Dagmar ŠPINAR Jindřich

Year of publication 2012
Type Article in Periodical
Magazine / Source Journal of Critical Care
MU Faculty or unit

Faculty of Medicine

Citation
Doi http://dx.doi.org/10.1016/j.jcrc.2012.03.011
Field Cardiovascular diseases incl. cardiosurgery
Keywords Uric acid; Acute heart failure; Allopurinol; Mortality
Description Study Objective: The aim of this study was to explore the prognostic role of serum uric acid (UA) measurement in the hospital and long-term mortality assessment in subjects with acute heart failure (AHF) from the Acute HEart FAilure Database registry (AHEAD). The AHEAD registry comprised 4153 patients with AHF syndromes hospitalized at the AHEAD participating centers. Patients and Methods: The study included 1255 patients who were admitted to the AHEAD participating centers with acute decompensated chronic heart failure, de novo heart failure, or cardiogenic shock between September 2006 and October 2009 and who had information about serum UA concentration available at the time of hospital admission. The hospital and long-term mortality was followed using the centralized database of the Ministry of Health, Czech Republic.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.